Oncologists' attitudes toward KRAS testing: a multisite study

Recent discoveries promise increasingly to help oncologists individually tailor anticancer therapy to their patients’ molecular tumor characteristics. One such promising molecular diagnostic is Kirsten ras (KRAS) tumor mutation testing for metastatic colorectal cancer (mCRC) patients. In the current...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Harris, Julie N, Liljestrand, Petra, Alexander, Gwen L, Goddard, Katrina A B, Kauffman, Tia, Kolevska, Tatjana, McCarty, Catherine, O'Neill, Suzanne, Pawloski, Pamala, Rahm, Alanna, Williams, Andrew, Somkin, Carol P
Формат: Artigo
Язык:Inglês
Опубликовано: Blackwell Publishing Ltd 2013
Предметы:
Clinical Cancer Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3892392/
https://ncbi.nlm.nih.gov/pubmed/24403261
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.135
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы